Company, Human health, Animal health
We are pleased to share that Revatis has been granted a new patent covering the therapeutic use of the secretome and extracellular vesicles (EVs) derived from muscle-derived mesenchymal stem cells (mdMSCs).
This patent was obtained in the framework of an industrial doctoral program, reflecting the close integration of academic research and company-driven innovation.
A meaningful step for our team and for the continued development of cell-free biological approaches at Revatis.
#stemcells #celltherapy #secretome #exosomes #extracellularvesicles #regenerativemedicine